289 related articles for article (PubMed ID: 29914292)
1. From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation.
Salloum NC; Buchalter ELF; Chanani S; Espejo G; Ismail MS; Laine RO; Nageeb M; Srivastava AB; Trapp N; Trillo L; Vance E; Wenzinger M; Hartz SM; David SP; Chen LS
Pharmacogenomics; 2018 Jul; 19(10):861-871. PubMed ID: 29914292
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6).
Chen LS; Bloom AJ; Baker TB; Smith SS; Piper ME; Martinez M; Saccone N; Hatsukami D; Goate A; Bierut L
Addiction; 2014 Jan; 109(1):128-137. PubMed ID: 24033696
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of nicotine addiction: role of dopamine.
Herman AI; DeVito EE; Jensen KP; Sofuoglu M
Pharmacogenomics; 2014 Feb; 15(2):221-34. PubMed ID: 24444411
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic Optimization of Smoking Cessation Treatment.
Chenoweth MJ; Tyndale RF
Trends Pharmacol Sci; 2017 Jan; 38(1):55-66. PubMed ID: 27712845
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics of Nicotine Metabolism: Novel CYP2A6 and CYP2B6 Genetic Variation Patterns in Alaska Native and American Indian Populations.
Claw KG; Beans JA; Lee SB; Avey JP; Stapleton PA; Scherer SE; El-Boraie A; Tyndale RF; Nickerson DA; Dillard DA; Thummel KE; Robinson RF
Nicotine Tob Res; 2020 May; 22(6):910-918. PubMed ID: 31241144
[TBL] [Abstract][Full Text] [Related]
6. SNPs within CHRNA5-A3-B4 and CYP2A6/B6, nicotine metabolite concentrations and nicotine dependence treatment success in smokers.
Hubacek JA; Kurcova I; Maresova V; Pankova A; Stepankova L; Zvolska K; Lanska V; Kralikova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2021 Mar; 165(1):84-89. PubMed ID: 31796940
[TBL] [Abstract][Full Text] [Related]
7. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking.
Tyndale RF; Zhu AZ; George TP; Cinciripini P; Hawk LW; Schnoll RA; Swan GE; Benowitz NL; Heitjan DF; Lerman C;
PLoS One; 2015; 10(5):e0128109. PubMed ID: 26010901
[TBL] [Abstract][Full Text] [Related]
8. Beyond cigarettes per day. A genome-wide association study of the biomarker carbon monoxide.
Bloom AJ; Hartz SM; Baker TB; Chen LS; Piper ME; Fox L; Martinez M; Hatsukami D; Johnson EO; Laurie CC; Saccone NL; Goate A; Bierut LJ
Ann Am Thorac Soc; 2014 Sep; 11(7):1003-10. PubMed ID: 25072098
[TBL] [Abstract][Full Text] [Related]
9. Pathways to precision medicine in smoking cessation treatments.
Chen LS; Horton A; Bierut L
Neurosci Lett; 2018 Mar; 669():83-92. PubMed ID: 27208830
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
Tomaz PRX; Santos JR; Scholz J; Abe TO; Gaya PV; Negrão AB; Krieger JE; Pereira AC; Santos PCJL
BMC Med Genet; 2018 Apr; 19(1):55. PubMed ID: 29621993
[TBL] [Abstract][Full Text] [Related]
11. The Role of Pharmacogenetics in Smoking.
El-Boraie A; Tyndale RF
Clin Pharmacol Ther; 2021 Sep; 110(3):599-606. PubMed ID: 34165800
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism.
Perez-Paramo YX; Lazarus P
Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):333-349. PubMed ID: 33322962
[No Abstract] [Full Text] [Related]
13. Preparing the Way: Exploiting Genomic Medicine to Stop Smoking.
Bierut LJ; Tyndale RF
Trends Mol Med; 2018 Feb; 24(2):187-196. PubMed ID: 29307500
[TBL] [Abstract][Full Text] [Related]
14. Tobacco addiction and pharmacogenetics of nicotine metabolism.
Swan GE; Lessov-Schlaggar CN
J Neurogenet; 2009; 23(3):262-71. PubMed ID: 19152209
[TBL] [Abstract][Full Text] [Related]
15. A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
Loukola A; Buchwald J; Gupta R; Palviainen T; Hällfors J; Tikkanen E; Korhonen T; Ollikainen M; Sarin AP; Ripatti S; Lehtimäki T; Raitakari O; Salomaa V; Rose RJ; Tyndale RF; Kaprio J
PLoS Genet; 2015; 11(9):e1005498. PubMed ID: 26407342
[TBL] [Abstract][Full Text] [Related]
16. 'Smoking genes': a genetic association study.
Verde Z; Santiago C; Rodríguez González-Moro JM; de Lucas Ramos P; López Martín S; Bandrés F; Lucia A; Gómez-Gallego F
PLoS One; 2011; 6(10):e26668. PubMed ID: 22046326
[TBL] [Abstract][Full Text] [Related]
17. SNPs within CHRNA5-A3-B4 and CYP2A6/B6 are associated with smoking dependence but not with tobacco dependence treatment outcomes in the Czech population.
Hubacek JA; Pankova A; Stepankova L; Zvolska K; Adamkova V; Lanska V; Kralikova E
Gene; 2017 Mar; 606():35-38. PubMed ID: 28069549
[TBL] [Abstract][Full Text] [Related]
18. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
[TBL] [Abstract][Full Text] [Related]
19. Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled Trial.
Chen LS; Baker TB; Miller JP; Bray M; Smock N; Chen J; Stoneking F; Culverhouse RC; Saccone NL; Amos CI; Carney RM; Jorenby DE; Bierut LJ
Clin Pharmacol Ther; 2020 Dec; 108(6):1315-1325. PubMed ID: 32602170
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme.
Bray MJ; Chen LS; Fox L; Hancock DB; Culverhouse RC; Hartz SM; Johnson EO; Liu M; McKay JD; Saccone NL; Hokanson JE; Vrieze SI; Tyndale RF; Baker TB; Bierut LJ
Genet Epidemiol; 2020 Oct; 44(7):748-758. PubMed ID: 32803792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
